Search Results 3451-3460 of 19770 for celiac disease

1. A Study of the Safety And Effectiveness of Palbociclib Plus Cetuximab versus Cetuximab Alone to Treat Head and Neck Cancer - Mayo Clinic

   ... and neck. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

2. Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss - Mayo Clinic

   This study aims to demonstrate that the investigational drug AUT00063 is effective and safe in the treatment of age-related hearing loss. Participation ...

3. 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

4. A Study of Outcomes for Patients and Caregivers Receiving Bone Marrow Transplant (BMT) by Providing a Caregiving Educational Intervention - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

5. Stress Management and Resilience Training (SMART) Intervention for Family Caregivers of Individuals With Advanced Cancer - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

6. A Study to Determine the Changes to Visual Fields and Neuropsychological Assessments after Laser Ablation for Epilepsy - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

7. Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

8. Reporting of Side Effects Among Stage III and IV Melanoma Patients Treated with Immune Checkpoint Inhibitors - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. Understanding the Genetic and Molecular Basis of Lipodystrophy - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

10. A Study of Characteristics and Post-surgical Outcomes of Pediatric Patients Diagnosed with Lipoblastoma - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...